Inhibition of monomethylarsonous acid (MMAIII)-induced cell malignant transformation through restoring dysregulated histone acetylation
Authors:
- Yichen GeYGYichen Ge
- Zhihong GongZGZhihong Gong
- James R. OlsonJOJames R. Olson
- Peilin XuPXPeilin Xu
- Michael J. BuckMBMichael J. Buck
- Xuefeng RenXRXuefeng Ren
- 1 October 2013
- journal article
- Published by Elsevier in Toxicology
- Vol. 312, 30-35
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acidToxicology, 2012
- Quantitative mass spectrometry reveals the epigenome as a target of arsenicChemico-Biological Interactions, 2011
- An Emerging Role for Epigenetic Dysregulation in Arsenic Toxicity and CarcinogenesisEnvironmental Health Perspectives, 2011
- Associations of Plasma Selenium with Arsenic and Genomic Methylation of Leukocyte DNA in BangladeshEnvironmental Health Perspectives, 2011
- Monomethylarsonous Acid Produces Irreversible Events Resulting in Malignant Transformation of a Human Bladder Cell Line Following 12 Weeks of Low-Level ExposureToxicological Sciences, 2010
- Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T‐cell lymphomaBritish Journal of Haematology, 2009
- Acetylated H4K16 by MYST1 protects UROtsa cells from arsenic toxicity and is decreased following chronic arsenic exposureToxicology and Applied Pharmacology, 2009
- Combination of DNA methylation inhibitor 5‐azacytidine and arsenic trioxide has synergistic activity in myelomaEuropean Journal of Haematology, 2009
- Epigenetic remodeling during arsenical-induced malignant transformationCarcinogenesis, 2008
- Monomethylarsonous acid induces transformation of human bladder cellsToxicology and Applied Pharmacology, 2006